Clinical Trials Directory

Trials / Unknown

UnknownNCT04183075

Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture

Clinical Trial to Assess the Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Elderly Patients With Spontaneous Hip Fracture

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
82 (estimated)
Sponsor
Laboratorios Ordesa · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Multicenter, prospective, randomized, double-blind, interventional study with a nutritional supplement against placebo in a cohort of patients hospitalized for hip fracture.

Detailed description

Hip fracture is a very prevalent pathology in the elderly population. It is estimated that 35-40% of people over 65 suffer a drop per year, and above 75 years this percentage is even higher, with hip fractures being one of the most serious consequences.With regard to malnutrition, the investigators know that aging carries an increased risk of suffering from decreased appetite and intake and changes in body composition. According to different series, the percentage of malnutrition in patients with hip fracture ranges from 13% to 60%. According to the hospital protocols in Spain in elderly people with spontaneous hip fracture, it is important to perform a nutritional screening during the first 24-48 hours of admission, to evaluate their nutritional status and apply a dietary treatment. The IRENE study aims to determine whether phase angle and reactance, measured by electrical bioimpedance by vector analysis (BIVA) are related to functional recovery in patients with hip fracture.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFontActiv Superprotein/Hypercaloric FiberThe product under study has a liquid presentation, in 200 ml bottles, ready to take
DIETARY_SUPPLEMENTCarbohydrates and C VitaminThe control product will be prepared with equal presentation and taste as similar as possible tan study product

Timeline

Start date
2020-09-01
Primary completion
2021-05-01
Completion
2021-05-01
First posted
2019-12-03
Last updated
2020-09-18

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04183075. Inclusion in this directory is not an endorsement.